Valued at $12.8 billion by market cap, DaVita Inc. (DVA) is a prominent healthcare company specializing in kidney care and ...

A Communications Equipment Company Showing Promise as a Solid Momentum Pick and a Medical Company with Strong Growth Characteristics.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

On May 6, Deutsche Bank upgraded DaVita Inc. (NYSE:DVA) from Hold to Buy and raised its price target to $220 from $126.The ...

Operator: Good evening. My name is Michelle, and I will be your conference facilitator today. At this time, I would like to ...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of ...

DaVita (DVA) stock jumped after the dialysis services provider reported better-than-expected Q1 2026 financials and raised ...

After selling DaVita Medical Group in 2019, DaVita focuses on providing services to end-stage renal disease, or ESRD, patients primarily in the United States, although its international footprint is ...

Q1 2026 earnings call insights: raised guidance, volume outlook, AI ScheduleHub efficiency, and ACA/RPT risks.

DaVita on Tuesday raised its forecast for annual adjusted profit ​after beating Wall Street estimates for ‌first-quarter results, betting on steady demand for its kidney dialysis services.

On a per-share basis, the Denver-based company said it had net income of $2.87. The kidney dialysis provider posted revenue of $3.42 billion in the period. DaVita HealthCare expects full-year earnings ...